Brandon May

A study of infants who presented to the emergency department with anaphylaxis may better inform treatment in these patients.

The study suggests this treatment approach may provide a safe and effective means of preventing allergic reactions associated with peanut protein in children younger than age 4.

Certain clinical predictors of poor response can guide the use of longer, higher-dose treatment.

Mobile health apps can collect real-world data and assist in rhinitis and rhinosinusitis management, but a new study suggests that more work is needed to validate their clinical applicability.

In pediatric patients with atopic dermatitis, a new study found that treatment with dupilumab significantly reduces symptoms and biomarkers related to disease severity.

A new practice guideline for the treatment of patients with eating disorders.

The American Academy of Pediatrics released clinical practice guidelines for the evaluation and treatment of obesity in children and adolescents.

Researchers investigated the safety and efficacy of microencapsulated benzoyl peroxide cream for improving papulopustular rosacea.

Poster presenters at AAD 2023 evaluate sociodemographic factors associated with delayed care in patients with skin cancer.

ASCO has released a guideline rapid recommendation update addressing radiotracers used for prostate-specific membrane antigen (PSMA) positron-emission tomography (PET) diagnostic imaging for selecting patients with metastatic castration-resistant prostate cancer (mCRPC) to receive lutetium-177–labeled PSMA-617 (LuPSMA) radioligand therapy. 1 The new recommendation, which updates the initial 2014 guideline and subsequent 2022 update, recommends three radiotracers, including the newly approved flotufolastat F-18, to determine eligibility in mCRPC. 2,3